Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health
31 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc.
27 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Open For Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation
25 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 25, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
U.K. Member of Parliament Crispin Blunt To Inaugurate Psilocybin Cultivation Facility At Optimi Health Grand Opening
19 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
17 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 17, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Optimi Health Completes Expansion Of On-Site Analytical Laboratory
11 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed a...
Optimi Health Applauds Health Canada’s Position on Drug Quality and Goods and Manufacturing Practices (GMP) for Psilocybin
09 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 09, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”) CEO, Bill Ciprick, issued a statement today in...
Optimi Health Granted Amendment To Controlled Substances Dealer’s Licence
04 mai 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 04, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that a requested Amendment...
Optimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility
28 avr. 2022 14h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, April 28, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it will be...
Optimi Health Begins Cultivation Of Natural Psilocybin For Use In Clinical Trials
18 mars 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has commenced...